90 related articles for article (PubMed ID: 21790217)
1. An upstream estrogen response element linked to exogenous p53 tumor suppressor gene expression differentiates effects of the codon 72 polymorphism.
Honda K; Kajitani K; Nobeyama H; Kira Y; Yabunaka Y; Egami M; Zhi X; Fukuda T; Yoshida H; Matsumoto Y; Ichimura T; Yaui T; Sumi T; Ishiko O
Asian Pac J Cancer Prev; 2011; 12(4):865-8. PubMed ID: 21790217
[TBL] [Abstract][Full Text] [Related]
2. Human Papillomavirus E6 Knockdown Restores Adenovirus Mediated-estrogen Response Element Linked p53 Gene Transfer in HeLa Cells.
Kajitani K; Honda K; Terada H; Yasui T; Sumi T; Koyama M; Ishiko O
Asian Pac J Cancer Prev; 2015; 16(18):8239-45. PubMed ID: 26745067
[TBL] [Abstract][Full Text] [Related]
3. Lack of evidence that proline homozygosity at codon 72 of p53 and rare arginine allele at codon 31 of p21, jointly mediate cervical cancer susceptibility among Indian women.
Bhattacharya P; Sengupta S
Gynecol Oncol; 2005 Oct; 99(1):176-82. PubMed ID: 16054204
[TBL] [Abstract][Full Text] [Related]
4. Differential levels of transcription of p53-regulated genes by the arginine/proline polymorphism: p53 with arginine at codon 72 favors apoptosis.
Jeong BS; Hu W; Belyi V; Rabadan R; Levine AJ
FASEB J; 2010 May; 24(5):1347-53. PubMed ID: 20019240
[TBL] [Abstract][Full Text] [Related]
5. p53 polymorphic variants at codon 72 exert different effects on cell cycle progression.
Pim D; Banks L
Int J Cancer; 2004 Jan; 108(2):196-9. PubMed ID: 14639602
[TBL] [Abstract][Full Text] [Related]
6. Role of p53 codon 72 arginine allele in cell survival in vitro and in the clinical outcome of patients with advanced breast cancer.
Vannini I; Zoli W; Tesei A; Rosetti M; Sansone P; Storci G; Passardi A; Massa I; Ricci M; Gusolfino D; Fabbri F; Ulivi P; Brigliadori G; Amadori D; Bonafe M
Tumour Biol; 2008; 29(3):145-51. PubMed ID: 18612219
[TBL] [Abstract][Full Text] [Related]
7. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells.
Girgert R; Hanf V; Emons G; Gründker C
J Pineal Res; 2009 Aug; 47(1):23-31. PubMed ID: 19522736
[TBL] [Abstract][Full Text] [Related]
8. [Interaction of p53 with p53 response element like binding sequence at upstream of hepatitis B virus enhancer I].
Qu JH; Zhu MH; Lin J; Ni CR; Li FM; Zhu Z; Yu GZ
Ai Zheng; 2004 May; 23(5):502-7. PubMed ID: 15142443
[TBL] [Abstract][Full Text] [Related]
9. The p53 codon 72 proline allele is associated with p53 gene mutations in non-small cell lung cancer.
Hu Y; McDermott MP; Ahrendt SA
Clin Cancer Res; 2005 Apr; 11(7):2502-9. PubMed ID: 15814626
[TBL] [Abstract][Full Text] [Related]
10. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential.
Dumont P; Leu JI; Della Pietra AC; George DL; Murphy M
Nat Genet; 2003 Mar; 33(3):357-65. PubMed ID: 12567188
[TBL] [Abstract][Full Text] [Related]
11. Arginine and proline alleles of the p53 gene are associated with different locations of gastric cancer.
Lai KC; Chen WC; Tsai FJ; Li SY; Jeng LB
Hepatogastroenterology; 2005; 52(63):944-8. PubMed ID: 15966238
[TBL] [Abstract][Full Text] [Related]
12. p53 codon 72 polymorphism as a risk factor in the development of breast cancer.
Papadakis EN; Dokianakis DN; Spandidos DA
Mol Cell Biol Res Commun; 2000 Jun; 3(6):389-92. PubMed ID: 11032762
[TBL] [Abstract][Full Text] [Related]
13. The codon 72 polymorphism of p53 influences cell fate following nutrient deprivation.
Kung CP; Liu Q; Murphy ME
Cancer Biol Ther; 2017 Jul; 18(7):484-491. PubMed ID: 28475405
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of the proline form of p53 codon 72 polymorphism in nasopharyngeal carcinoma.
Tsai MH; Lin CD; Hsieh YY; Chang FC; Tsai FJ; Chen WC; Tsai CH
Laryngoscope; 2002 Jan; 112(1):116-9. PubMed ID: 11802048
[TBL] [Abstract][Full Text] [Related]
15. Association of p53 and p21(CDKN1A/WAF1/CIP1) polymorphisms with oral cancer in Taiwan patients.
Bau DT; Tsai MH; Lo YL; Hsu CM; Tsai Y; Lee CC; Tsai FJ
Anticancer Res; 2007; 27(3B):1559-64. PubMed ID: 17595776
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer.
Ramondetta L; Mills GB; Burke TW; Wolf JK
Clin Cancer Res; 2000 Jan; 6(1):278-84. PubMed ID: 10656459
[TBL] [Abstract][Full Text] [Related]
17. P53 (Pro72Arg) polymorphism associated with the risk of oral squamous cell carcinoma in gutka, niswar and manpuri addicted patients of Pakistan.
Saleem S; Azhar A; Hameed A; Khan MA; Abbasi ZA; Qureshi NR; Ajmal M
Oral Oncol; 2013 Aug; 49(8):818-23. PubMed ID: 23683469
[TBL] [Abstract][Full Text] [Related]
18. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK
Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the frequency of TP53 gene codon 72 polymorphisms in Iranian patients with endometrial cancer.
Ghasemi N; Karimi-Zarchi M; Mortazavi-Zadeh MR; Atash-Afza A
Cancer Genet Cytogenet; 2010 Jan; 196(2):167-70. PubMed ID: 20082853
[TBL] [Abstract][Full Text] [Related]
20. [Study on the relationship between cervical cancer and p53 codon 72 polymorphism].
Qie M; Zhang Y; Wu J
Hua Xi Yi Ke Da Xue Xue Bao; 2002 Apr; 33(2):274-5. PubMed ID: 12575207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]